Inclusive

It’s #SexualHealthAwarenessWeek. Millions of sexually transmitted infections go undetected each year, and AMR is making some harder to treat. Smarter, faster, more inclusive research is essential. Read our full post: www.facebook.com/researchgrid/.

🚀 Research Grid is officially launching in the United States!

We’re kicking things off at #DPharm2025, discussing what matters most: how we can make clinical trials faster, more efficient, and more successful.

AI is changing oncology, but progress depends on both science and operational efficiency. Being listed alongside other innovators highlights why automating the hidden work in clinical trials matters: faster trials mean faster patient benefit: www.plugandplaytechcenter.com/insights/ai-...

Research Grid CEO Dr Amber Hill will speak at #DPHARM2025 in Philadelphia on Sept 16, sharing AI case studies showing how admin-free clinical trials are becoming a reality.

Safeguarding Data Security in the Age of Digital Clinical Trials Clinical trials are increasingly leveraging digital tools, real-time data sharing, and seamless collaboration to accelerate trial…

Clinical trials are going digital, and with that comes new data security considerations. But did you know that the right technology can make trials more secure than ever? Read our blog post here: medium.com/@researchgri....

U.S. Clinical Trials Market Size to Surpass USD 75.39 Billion by 2034

There are currently 22,985 clinical trials recruiting patients in the US: www.biospace.com/press-releas....

With 97,000 health-focused communities, Inclusive can connect these trials to the people they're looking for, quickly, directly, and at scale.

🚀 Launching Site Feasibility by Research Grid: AI-powered planning, instant insights, and global site search to reduce startup timelines from months to days. Smarter feasibility starts here: inclusive.health/solutions/si....

World Hepatitis Day 2025’s theme, ‘Let’s break it down,’ highlights the need to remove barriers to treatment and research. With 300M affected, many unaware or untreated, inclusive research is vital. Tech-enabled outreach can connect communities and accelerate progress.

Rare Cancers Bill 2024-2025 The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a priv...

The Rare Cancers Bill addresses challenges in trial recruitment for fairer, faster research: commonslibrary.parliament.uk/research-bri....

At R.grid, we believe that true progress in rare disease trials starts with connecting with patients. See how Inclusive can help at inclusive.health.

The consent form isn’t just a box to tick. It’s where trust begins. That’s what eConsent is for. Read more: trialengine.ai/solutions/ec...

A Simple Way to Close Racial Gaps in Cancer Trial Enrollment When offered the opportunity to participate in clinical trials, patients with breast cancer across racial and ethnic groups are equally likely to do so, according to a recent survey.

Black and Hispanic patients are as willing as others to participate in research when given the chance, they just haven't been asked: www.medscape.com/viewarticle/....

Inclusive helps bridge this gap by connecting researchers with thousands of communities for better, more equitable trial outreach.

AI is transforming clinical trials, but most pharma companies still aren’t applying it where it matters most: the back office. TrialEngine, our end-to-end clinical trial automation system, changes that. Read more: www.linkedin.com/posts/rgrid_....

Achieving inclusivity in clinical research Diversity and inclusivity in clinical research, including in clinical trial participation, are essential to ensure that the development of innovative medicines meets the needs of patient populations.

The ABPI and AMRC are calling for a UK strategy to improve clinical research diversity: www.abpi.org.uk/publications....

Inclusive is built to help researchers deliver this goal by automating outreach, simplifying engagement, and making it easier to involve underserved communities from the start.

𝗧𝗼𝗽 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝘁𝗼𝗿𝗶𝗲𝘀 𝗳𝗿𝗼𝗺 𝗤𝟮 𝟮𝟬𝟮𝟱 | R.grid 𝗧𝗼𝗽 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝘁𝗼𝗿𝗶𝗲𝘀 𝗳𝗿𝗼𝗺 𝗤𝟮 𝟮𝟬𝟮𝟱 The industry is in flux. In just a few months, we’ve seen deep cuts to public funding in the US, major reforms in the UK, and a shifting power balance in gl...

Q2 2025 brings funding freezes in the US, bold reforms in the UK, and a rapidly shifting global balance in trials. The landscape is changing fast, and those with the right systems in place will be ready to lead.
Read more: www.linkedin.com/feed/update/....

3 ways Walgreens Clinical Trials is meeting patients where they are Highlights from the third annual Walgreens Clinical Trials Day event.

Supported by R.grid’s technology, Walgreens highlights how connecting with communities helped them reach 17M potential participants: www.walgreensbootsalliance.com/news-media/o....

Inclusive scales this approach, making it easy for researchers to engage with thousands of community groups worldwide.

Ministers plan to use NHS app to expand clinical trials as part of UK-wide drive Patients in England will be matched with studies and encouraged to take part via smartphone notifications

Technology is making research more accessible than ever, with the NHS app set to be the ‘digital front door’ for clinical trials: www.theguardian.com/society/2025....

Inclusive takes this a step further, integrating communities into every step of research: inclusive.health.

Our CEO Dr Amber Hill is heading to DC for the DIA 2025 Global Annual Meeting.

She’ll be speaking on the Overcoming Site Burden panel about how smart automation makes trials faster and more successful.

If you’re thinking seriously about reducing site burden, catch her after the session.

A productive week at Research Grid! We’re excited to welcome 4 new team members to our UK team as we prepare for hypergrowth and finalize new features for our clients.

AI automates 3 years of clinical trial data in seconds. Research Grid’s AI cut $1.5M data entry costs to $6K, saved 24,000+ staff hours, and eliminated 5% error in a 688-patient QMUL cardiac trial. Find out how it could transform research and care: partners.time.com/partners/res....

‘Concerning’ lack of female-only medical trials in UK, say health experts Exclusive: doctors and patients forced to make decisions in ‘vacuum of evidence’ as women under-represented in data

Male-only clinical studies outnumber female-only by 67%, partly due to the false belief that women don’t want to participate: www.theguardian.com/society/2025....

Connecting communities and researchers is key to revealing insights and creating more opportunities. Inclusive makes this happen.

Celebrating #PrideMonth with our LGBTQIA+ communities! In clinical research, inclusion means the difference between equitable care and systemic neglect. Change starts with visibility, voice, and meaningful involvement. Read more:
www.linkedin.com/feed/update/...
#InclusiveResearch #LGBTQHealth

A once-in-a-lifetime breakthrough not just for Research Grid, but for society.

Congratulations to the whole Research Grid team, for becoming one of the first in the world to be granted multiple patents for the use of AI in automating patient engagement and clinical trial operations.

It was great to be back at Patients as Partners EU this week and to once again join the industry leaders rethinking what true patient involvement looks like.
If you’re working to make trials more inclusive and diverse as well as faster, we’d love to talk.
#PatientsEU

Today is #ClinicalTrialsDay. Clinical research is powered by people—patients, communities, and researchers. But too often, they’re held back by admin and outdated systems. At Research Grid, we automate the work that slows them down. That’s what it means to be #PoweredByPurpose.

We're heading to the Patients as Partners Europe conference next week!

If you're attending, come find the Research Grid team at booth 7 - we’d love to connect.

See you in London!
#PatientsEU2025

‘Children with cancer cannot wait’: the human cost of clinical trial delays after Brexit Exclusive: Price of importing drugs for a Paris and Birmingham study has almost quadrupled to £175,000

Brexit has increased the costs of UK cancer trials — where one study saw import costs rise almost 4x.
www.theguardian.com/politics/202....

With trial costs rising, technology can ease the load. Research Grid reduces administration spending by up to 45%, saving resources where it counts.

Access to health data is catching up with the ambition of medical research… | R.grid Access to health data is catching up with the ambition of medical research in Europe. New government programs are aiming to cut red tape around clinical data access, tackling one of the most signific...

Government programs in the UK & EU are tackling data access bottlenecks in clinical research. We believe AI can take it further, automating data management and empowering researchers to design smarter trials. Check out our latest post to learn more: www.linkedin.com/feed/update/....

Trump’s Stance Doesn’t End Need for Diversity in Clinical Trials The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Ethnic minorities make up 40% of the US population – yet, they only make up 20% of oncology trial participants: www.ajmc.com/view/trump-s.... Inclusive was built to help researchers close this gap by helping researchers connect with underrepresented communities: inclusive.health.

First-ever MHRA analysis of UK clinical trial applications finds new opportunities to drive medical breakthroughs for patients New analysis of the current clinical trial landscape in the UK shows clear opportunities to shape the future of medical research and patient care.

The MHRA’s analysis of the UK clinical trial industry highlights the UK as a global leader: www.gov.uk/government/n....

However, excessive admin continues to hold researchers back. To truly strengthen the UK’s position, we need AI to make trials admin-free. We make that possible: rgrid.tech.

As US ditches diversity in clinical trials, all eyes on Europe | Context by TRF Trump rollback on DEI stifles global efforts to close racial health disparities laid bare by COVID

Only 41% of ethnic minority survey respondents are willing to join clinical trials, compared to 61% of white respondents:
www.context.news/socioeconomi....

Inclusive offers researchers a way to address this gap: by supporting them to better reach and engage diverse community groups early on.